特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

敗血症:世界の治験動向

Sepsis Global Clinical Trials Review, H2, 2019

発行 GlobalData 商品コード 212857
出版日 ページ情報 英文 586 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.27円で換算しております。
敗血症:世界の治験動向 Sepsis Global Clinical Trials Review, H2, 2019
出版日: 2019年12月13日 ページ情報: 英文 586 Pages
概要

当レポートでは、敗血症治療薬に関する治験の最新動向について分析しており、主要7カ国 (G7) および新興7カ国 (E7) における治験件数、被験者数、有望なスポンサー、治験に携わっている主な企業や機関、有望な薬剤の情報をまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:感染症治療薬の治験における敗血症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症治療薬の治験における敗血症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

敗血症治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

  • Sepsis Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Sepsis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Sepsis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
  • Sepsis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
  • Sepsis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
  • Sepsis Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
  • Sepsis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
  • Sepsis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
  • Proportion of Sepsis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 16
  • Sepsis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
  • Sepsis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
  • Proportion of Sepsis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 19
  • Sepsis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
  • Sepsis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
  • Sepsis Therapeutics, Global, Clinical Trials by Phase, 2019* 22
  • Sepsis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
  • Sepsis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
  • Sepsis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
  • Sepsis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
  • Sepsis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
  • Sepsis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
  • Sepsis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
  • Sepsis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

List of Figures

  • Sepsis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Sepsis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Sepsis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
  • Sepsis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
  • Sepsis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
  • Sepsis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
  • Sepsis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
  • Sepsis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
  • Proportion of Sepsis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 16
  • Sepsis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
  • Sepsis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
  • Proportion of Sepsis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 19
  • Sepsis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
  • Sepsis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
  • Sepsis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
  • Sepsis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
  • Sepsis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
  • Sepsis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
  • Sepsis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
  • Sepsis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
  • Sepsis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
  • Sepsis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
  • Sepsis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
  • GlobalData Methodology 589
目次
Product Code: GDHC5200CTIDB

GlobalData's clinical trial report, "Sepsis Global Clinical Trials Review, H2, 2019" provides an overview of Sepsis clinical trials scenario. This report provides top line data relating to the clinical trials on Sepsis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Sepsis to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Sepsis to Infectious Disease Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Sepsis Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Sepsis 31
  • Nov 18, 2019: Enlivex Therapeutics completes recruitment in phase Ib trial evaluating safety and efficacy of universal off-the-shelf Allocetra in patients with severe sepsis 31
  • Nov 04, 2019: Enlivex Therapeutics announces positive interim safety and efficacy data from ongoing trial of off-the-shelf Allocetra in patients with severe sepsis 31
  • Oct 11, 2019: Aptahem announces strengthened research results with Apta-1 from completed NHP study 31
  • Oct 10, 2019: Preclinical data indicating Allocetra-OTS as potential therapy for prevention of organ failure and mortality associated with severe sepsis selected for presentation at the xviiith congress of the XVIIIth Congress Of the European and Int'l Shock Societies 32
  • Oct 03, 2019: Groundbreaking research points towards Exoxemis' Zempia as a proposed new weapon in Medicine's Armamentarium to Fight Sepsis 32
  • Sep 26, 2019: Shionogi to present data of cefiderocol at IDWeek 2019 33
  • Clinical Trial Profile Snapshots 35

Appendix 588

  • Abbreviations 588
  • Definitions 588
  • Research Methodology 589
  • Secondary Research 589
  • About GlobalData 590
  • Contact Us 590
  • Source 591